期刊文献+

胺碘酮联合β受体阻断药治疗冠脉搭桥术后早期新发房颤 被引量:1

The Effect of Amiodarone and β Blockers on 102 Cases of the Early Arrhythmia after Coronary Artery Bypass Grafting
下载PDF
导出
摘要 目的:观察胺碘酮联合β受体阻断药治疗冠状动脉搭桥(CABG)术后早期新发房颤(AF)的效果和不良反应。方法:102例CABG术后早期发生快室率房颤患者随机分为对照组48例和治疗组54例,对照组给予胺碘酮注射液静脉泵入,治疗组在对照组基础上加用艾司洛尔注射液或美托洛尔注射液。观察心电监护、心电图及24h动态心电图心率变化,比较两组1周内转复为窦性心律的有效率和不良反应发生率。结果:两组有效率分别为79.1%和94.4%,差异有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:胺碘酮联合艾司洛尔或美托洛尔转复CABG术后早期新发房颤效果优于单用胺碘酮。不良反应少,安全性高,值得临床推荐。 Objective:To investigate the effect and side effect of Amiodarone and β blockers on the arrhythmia af- ter Coronary artery bypass grafting(CABG). Methods :102 AF patients after CABG were randomly divided into two groups: Amiodarone group and Amiodarone and β blockers combined group. There were 48 cases with Amiodarone alone, 54 cases with Amiodarone and β blockers. The heart rate of ambulatory Hoher monitor, electrocardiogram (ECG) and dynamic elec- trocardiogram were recorded. The effective rate and complication rate of the two groups whose heart rate turned to sinus rhythm in one week were recorded. Results:The effective rate of combined group was superior to the Amiodarone group, 94.4% to 79.1% ( P 〈 0.05 ). The side effect had no difference in the two groups ( P 〉 0.05 ). Conclusion : Using com- bined group on AF patients after CABG can achieve better results comparing tO the Amiodarone group. Side effect is low and the combination drug therapy is worth to clinical recommenelation.
出处 《药物流行病学杂志》 CAS 2012年第6期260-262,共3页 Chinese Journal of Pharmacoepidemiology
关键词 冠状动脉搭桥术 房颤 胺碘酮 Β受体阻断药 Coronary artery bypass grafting Arrhythmia Amiodarone β blockers
  • 相关文献

参考文献7

二级参考文献19

  • 1Villareal RP,Hariharan R,Liu BC,et al.Postoperative atrial fibrillation and mortality after coronary artery bypass surgery[J].J Am Coil Cardiol,2004,43:742-748.
  • 2Amar D,Shi W,Hogue CW,et al.Clinical prediction rule for atrial fibrillion after coronary artery bypass grafting[J].J Am Coll Cardiol,2004,44:1248-1253.
  • 3David Bradley MD,Lawrence L,Creswell MD,et al.Atrial fibrillation:ACCP Guidelines[J].Chest,2005,128:39-47.
  • 4Shin H,Hashizume K,Lina Y,et al.Effects of atrial fibrilla-tion on coronary artery bypass graft flow[J].Eur J cardiothorac Surg,2003,23:175-178.
  • 5Charles W,Hogue Jr,Mary LH.Atrial fibrillation after cardiac operation:risks,mechanisms,and,treatment[J].Ann Thorac Surg,2000,69:300-306.
  • 6Yagdi T,Nalbantgil S,Ayik F,et al.Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting[J].J Thorac Cardiovasc Surg,2003,125:1420-1425.
  • 7Daoud EG,Strickberger SA,Man KC,et al.Preoperative ami-odarone as prophylaxis against atrial fibrillation after heart surgery[J].New Engl J Med,1997,337:1785-1791.
  • 8Shingawa K,Shiroshita-Takeshita A,Schram G,et al.Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium:insights into the mechanism of the superior efficacy of amioda-rone[J].Circulation,2003,107:1440-1446.
  • 9Mitchell LB,Exner DV,Wyse DG,et al.Prophylactic aminodarone for the prevention of arrhythmias that begin early(PA-PABEAR):Preliminary results[J].Circulation,2003,108:2723.
  • 10Buckley MS,Nolan PE,Slack MK,et al.Amiodarone dose response for the preventing atrial fibrillation following cardiac surgery:a meta-analysis[J].Pharmacotherapy,2004,24:1426.

共引文献5

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部